Sustained collaboration of national and regional cancer funders to support the Cancer Mission through translational research

This section details the eligibility criteria for applicants, the geographical scope of the program, and its overarching objectives. It is designed for networks of national and regional cancer funders across Europe, focusing on improving the lives of cancer patients through collaborative translational research and innovation, ensuring equitable access, and accelerating digital transformation in health systems.

This section outlines the types of projects, thematic areas, and specific activities supported by the program. It also clarifies eligible and excluded costs, focusing on translational cancer research across various stages of development to achieve the Cancer Mission's objectives.

This section outlines the critical administrative, operational, and financial stipulations for applicants and beneficiaries under this funding program. It covers application rules, consortium requirements, and budgetary conditions, ensuring compliance with Horizon Europe guidelines.

This section guides applicants through the process of preparing and submitting proposals for the Cancer Mission funding, detailing the procedural steps, evaluation methods, and available support resources. It outlines how applications are assessed and how funding decisions are communicated to ensure transparency and efficiency.

This section identifies the fundamental legal and official documents that underpin and govern the 'Sustained collaboration of national and regional cancer funders to support the Cancer Mission through translational research' program. These documents provide the regulatory framework and legitimacy for the funding initiative.